BamSEC and AlphaSense Join Forces
Learn More

Provectus Biopharmaceuticals Inc

OTC: PVCT    
Share price (12/20/24): $0.12    
Market cap (12/20/24): $50.4 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 12 pages Amended Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 8 pages Common Share Stock Option Agreement
12/34/56
EX-10.1
from 8-K 9 pages Common Share Stock Option Agreement
12/34/56
EX-10.1
from 8-K ~1 page Financing Term Sheet by Provectus Biopharmaceuticals, Inc. Dated Effective: July 18, 2024
12/34/56
EX-10.1
from 8-K 3 pages Conversion Agreement
12/34/56
EX-10.2
from 8-K 12 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 12 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 43 pages University of Miami Exclusive License Agreement
12/34/56
EX-10.2
from 8-K 5 pages Independent Contractor Agreement
12/34/56
EX-10.1
from 8-K 7 pages Independent Contractor and Director Fee Termination Agreement and Release
12/34/56
EX-10.1
from 10-Q ~1 page Financing Term Sheet by Provectus Biopharmaceuticals, Inc. Dated Effective: September 20, 2022
12/34/56
EX-10.1
from 10-Q ~1 page Financing Term Sheet by Provectus Biopharmaceuticals, Inc. Dated Effective: August 13, 2021
12/34/56
EX-10.1
from 8-K 11 pages Indemnification Agreement
12/34/56
EX-10.39
from 10-K 3 pages 2020 Financing Term Sheet
12/34/56
EX-10.1
from 8-K 12 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amendment No. 2 to the Independent Contractor Agreement
12/34/56
EX-10.1
from 8-K 12 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 15 pages Secured Convertible Promissory Note
12/34/56
EX-10.4
from 10-Q 4 pages Material contract
12/34/56
EX-10.3
from 10-Q 4 pages Material contract
12/34/56